PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jneuromotThis ArticleAims and ScopeInstructions to AuthorsE-SubmissionJournal of Neurogastroenterology and Motility
 
J Neurogastroenterol Motil. 2010 October; 16(4): 374–388.
Published online 2010 October 30. doi:  10.5056/jnm.2010.16.4.374
PMCID: PMC2978390

Viewpoints on Acid-Induced Inflammatory Mediators in Esophageal Mucosa

Abstract

We have focused on understanding the onset of gastroesophageal reflux disease by examining the mucosal response to the presence of acid in the esophageal lumen. Upon exposure to HCl, inflammation of the esophagus begins with activation of the transient receptor potential channel vanilloid subfamily member-1 (TRPV1) in the mucosa, and production of IL-8, substance P (SP), calcitonin gene related peptide (CGRP) and platelet activating factor (PAF). Production of SP and CGRP, but not PAF, is abolished by the neural blocker tetrodotoxin suggesting that SP and CGRP are neurally released and that PAF arises from non neural pathways. Epithelial cells contain TRPV1 receptor mRNA and protein and respond to HCl and to the TRPV1 agonist capsaicin with production of PAF. PAF, SP and IL-8 act as chemokines, inducing migration of peripheral blood leukocytes. PAF and SP activate peripheral blood leukocytes inducing the production of H2O2. In circular muscle, PAF causes production of IL-6, and IL-6 causes production of additional H2O2, through activation of reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidases. Among these, NADPH oxidase 5 cDNA is significantly up-regulated by exposure to PAF; H2O2 content of esophageal and lower esophageal sphincter circular muscle is elevated in human esophagitis, causing dysfunction of esophageal circular muscle contraction and reduction in esophageal sphincter tone. Thus esophageal keratinocytes, that constitute the first barrier to the refluxate, may also serve as the initiating cell type in esophageal inflammation, secreting inflammatory mediators and pro-inflammatory cytokines and affecting leukocyte recruitment and activity.

Keywords: Cytokines, Gastroesophageal reflux disease, Platelet activating factor, Substance P, TRPV1

Introduction

Gastroesophageal reflux disease (GERD) is a common clinical condition, with approximately 20% of the adult Western population complaining of symptoms at least once per week.1-3 The pathophysiology of mucosal injury in GERD remains to be elucidated, but prolonged contact of mucosa with acid contributes to the reflux injury. Several publications have summarized the current understanding of the pathophysiology of GERD, but work on mechanisms of disease has focused primarily on damage to the tight junctions and loss of epithelial integrity in response to acid.4,5

It was thought that esophagitis may develop from a chemical injury starting at the luminal surface of the squamous epithelium, progressing through epithelium and lamina propria into the submucosa, resulting in acid-induced death of surface cells, and stimulation of a proliferative response in the basal cells.6 This view has recently been challenged; a description of the pathogenetic process has been provided,7 proposing that refluxed gastric juice does not directly damage the esophageal mucosa, but rather stimulates esophageal epithelial cells to secrete chemokines. These in turn attract and activate immune cells that damage the mature esophageal squamous epithelial cells7 similar to other immune processes of the gastrointestinal tract such as celiac disease where activated lymphocytes damage the mature villous cells. These data are also consistent with previous studies reporting that in experimental esophagitis in animals and in human reflux esophagitis pro-inflammatory cytokine production may underlie the development of erosive esophagitis,8-12 which is defined by the infiltration of neutrophils and eosinophils into the mucosa. In addition, in an animal model of acute esophagitis, Paterson et al13 showed that acid perfusion caused release of platelet activating factor (PAF) from esophageal mucosa into the lumen and induced significant epithelial injury, prevented by a PAF-antagonist. The data suggest that production of cytokines or chemokines and inflammatory mediators may originate in the mucosa and initiate the inflammatory process.

Except for one recent review,14 however, surprisingly little information is available about esophageal inflammation in GERD even though changes at the molecular level may occur prior to macroscopic signs of inflammation. In the following we will examine interaction of acid and esophageal mucosa, leading to production of cytokines and inflammatory mediators, as key events in the onset of esophageal inflammation.

Initial Events in GERD Pathophysiology

1. TRPV1 and acid sensors

In many inflammatory processes in several organ systems the initial cause of the inflammation is unknown. In esophagitis a likely cause is gastroesophageal reflux, containing HCl, enzymes and bile acids. In this review the effect of one of the components of gastric juice, HCl, has been examined, focusing on the mechanisms of its contribution to inflammation in normal esophageal squamous epithelium.

The squamous epithelial cells of the esophagus may respond to the presence of acid in its lumen through a variety of acid-sensing receptors. The transient receptor potential channel, vanilloid subfamily member-1 (TRPV1, also known as VR1), was originally described in primary sensory neurons as a receptor for capsaicin and related natural irritants (collectively referred to as vanilloids).15 TRPV1 is a non-selective cation channel expressed by sensory nerves. It is activated by heat, by the pungent ingredient of chili peppers, capsaicin, or by endogenous hydrogen ions released in tissues during inflammation15 or present in gastroesophageal reflux. TRPV1 is now believed to function as a molecular integrator of noxious stimuli, including acids, heat, pollutants with negative electric charge and endogenous pro-inflammatory substances.16 Up-regulated TRPV1 expression has been demonstrated in disease states of the gastrointestinal tract such as inflammatory bowel disease,17 irritable bowel syndrome18 and, more recently, esophagitis.19,20 TRPV1 activation in primary afferent neurons evokes the sensation of burning pain and induces neurogenic inflammation by the release of substance P (SP) and calcitonin-gene-related peptide (CGRP).17,21

2. TRPV1 and inflammation

TRPV1-induced "neurogenic inflammation" has been examined in several systems, particularly in the airways, and to a lesser extent in the digestive tract. In the digestive tract most publications have focused on the role of vanilloid receptor in inflammation, with emphasis on stimulation of SP release,22-31 or on a role of endopeptidases in degradation of SP, with a resulting decrease in inflammation.32-34 In the ileum and colon, TRPV1 is thought to be a mediator of inflammation because, in experimental models of colitis induced by dextran sulphate sodium,35,36 or of ileitis induced by Clostridium difficile toxin A28 or anandamide,27 inflammation is attenuated in response to TRPV1 channel blockers35,36 or after genetic deletion of TRPV1.37

To test whether this acid-sensitive receptor may be the initial mediator of acid-induced inflammation in the cat esophagus, a tubular segment of normal esophageal mucosa and submucosa was removed and tied at both ends to form a mucosal sac (Fig. 1).9 The sac was filled with 0.01 N HCl (or normal Krebs buffer as controls) and kept in oxygenated Krebs buffer at 37[degree celsius]. The medium around the HCl-filled sac (supernatant) was collected after 3 hour incubation and examined for content of inflammatory mediators.

Figure 1
We produced an in vitro model of esophageal inflammation using an esophageal mucosa tube tied at both ends. The tube was created by removing the muscle layers from the esophagus by sharp dissection at the interface between submucosa and circular mucle. ...

3. Substance P and calcitonin-gene-related peptide

SP and CGRP levels increased in mucosal tissue and in supernatant in response to HCl (Fig. 2 and and3)3) and the increases were abolished by the TRPV1 receptor antagonist 5'-iodoresinferratoxin (IRTX) or by neural block with tetrodotoxin, suggesting that TRPV1-induced production of SP and CGRP was neurally mediated. Increased levels of neurotransmitters in both mucosa and supernatant imply de novo production of both CGRP and SP, requiring the presence of neural cell bodies in the sac.

Figure 2
When in vitro mucosa is exposed to HCl for 3 hours, substance P levels increase 6-fold in the mucosa (A) and in the supernatant (B) when compared to control (pH 7.4) (*p < 0.05, ANOVA). The HCl-induced increase in substance P is abolished by the ...
Figure 3
When in vitro mucosa is exposed to HCl for 3 hours, calcitonin gene related peptide (CGRP) levels increase 200-fold in the mucosa (A) and 10-fold in the supernatant (B) when compared to control (pH 7.4) (*p < 0.05, ANOVA). The HCl-induced increase ...

In histological sections of esophagus, CGRP immunoreactivity is present in ganglion cells of the myenteric and submucosal plexus, with varying degrees of expression. SP immunoreactivity is detectable in small neurons and fibers, mainly scattered throughout the submucosal plexus. In addition fine SP-positive fibrils are distributed throughout the submucosa with occasional organization into longer and somewhat tortuous fibers (possibly axons) (Fig. 4).

Figure 4
Histological sections of cat esophagus immunostained to detect (A, B) calcitonin gene related peptide (CGRP) or (C, D) Substance P. Immunoreactivity was detected with secondary antibody tagged with horseradish peroxidase (HRP)-conjugated polymer and diaminobenzidine ...

4. Platelet activating factor

PAF is an important chemoattractant and activator of immune cells, with special emphasis on eosinophils.38 PAF is among the most important inducers of eosinophil function and evokes the release of reactive oxygen species by immune cells39,40 and by esophageal circular muscle.41,42

PAF levels increased in the HCl-filled mucosal sac and in its supernatant when compared to controls (Krebs filled mucosal sac at pH 7.4) (Fig. 5). The HCl-induced increase in PAF was abolished by the TRPV1 receptor antagonist IRTX but not by neural block with tetrodotoxin, indicating that production of PAF may arise from non-neural pathways, and most likely from the esophageal epithelium. TRPV1 receptors are present in non-neural cells, such as keratinocytes of the epidermis,43,44 in the human keratinocyte cell line HaCaT,43 in the human bronchial epithelial cell line BEAS-2B,21 in bladder urothelium and smooth muscle,45,46 liver,47 polymorphonuclear granulocytes48 and macrophages.49

Figure 5
When in vitro mucosa is exposed to HCl for 3 hours, platelet activating factor (PAF) levels increase 4-5 fold in the mucosa (A) and in the supernatant (B) when compared to control (pH 7.4) (*p < 0.05, ANOVA). The HCl-induced increase in PAF is ...

5. TRPV1 receptors are present in epithelial cells

The presence of TRPV1 receptor mRNA in esophageal mucosa was shown by reverse transcriptase-polymerase chain reaction (RT-PCR) (Fig. 6A). In feline keratinocytes enzymatically isolated and sorted by flow cytometry to a purity of 90%-95% RT-PCR confirms the presence of TRPV1 receptor mRNA (Fig. 6A). Western blot analysis confirms the presence of TRPV1 protein in epithelial cells purified with an epithelial cell selective pan-cytokeratin antibody (Fig. 6B).50-55

Figure 6
(A) To demonstrate the presence of the transient receptor potential channel vanilloid subfamily member-1 (TRPV1) receptor mRNA in non-neural cells, esophageal epithelial cells were enzymatically isolated and sorted by flow cytometry. Primers were derived ...

Production of PAF in esophageal epithelial cells, in response to TRPV1 activation has been confirmed in the human esophageal epithelial cell line HET-1A, where the sequential steps beginning with TRPV1 receptor activation and resulting in PAF production has been elucidated.56

6. TRPV1 receptor activation in the esophageal mucosa inhibits esophageal contraction

HCl-induced activation of TRPV1 receptors, affects contraction of esophageal circular muscle as electric field stimulation (EFS)-induced contraction of esophageal circular strips was almost abolished by incubation in the supernatant of the HCl-filled mucosal sac (Fig. 7). This supernatant-induced inhibition was reduced when the TRPV1 antagonist IRTX was present inside the mucosal sac, confirming the contribution of functional capsaicin-sensitive TRPV1 receptors in the mucosal wall.

Figure 7
Contraction of esophageal circular muscle (Control) in response to electrical field stimulation (EFS) is almost abolished by supernatant of HCl-filled mucosal sac (MHS). The reduction is reversed by application of the transient receptor potential channel ...

When TRPV1 is activated by the selective TRPV1 agonist capsaicin, the reduction in contraction caused by the sac supernatant is almost abolished by pre-exposure the TRPV1 antagonist IRTX, confirming a role of TRPV1 in this effect. The contraction is restored by the PAF receptor antagonist CV9388 (Fig. 8). This is consistent with release of PAF by epithelial cells in response to activation of TRPV1 by capsaicin and indicates that PAF is a major inflammatory mediator affecting circular muscle contraction.

Figure 8
Contraction of esophageal circular muscle (Control) in response to electrical field stimulation (EFS) is almost abolished by supernatant of capsaicin-filled mucosal sac (MCS). The reduction is reversed by application of the transient receptor potential ...

We conclude that HCl-induced activation of TRPV1 receptors in esophageal epithelial cells results in neurally mediated release of SP and CGRP, and non-neurally mediated release of PAF from the epithelium (Fig. 9).

Figure 9
HCl-induced activation of transient receptor potential channel vanilloid subfamily member-1 (TRPV1) receptors in esophageal mucosa results in neurally-mediated release of substance P (SP) and calcitonin gene related peptide (CGRP), and non-neurally mediated ...

7. TRPV1-induced release of inflammatory mediators in the human esophagus

Similarly to the cat, contraction of human esophageal circular muscle is affected by the inflammatory mediators released by the mucosa, rather than by diffusion of HCl through the mucosal barrier, because when human esophageal circular muscle is directly exposed to HCl (pH 4, 2-3 hours) no change in EFS-induced contraction occurs (Fig. 10). When the mucosal sac is filled with HCl at the same pH, however, its supernatant almost abolishes contraction in response to EFS and the inhibition is suppressed by PAF antagonists. This finding is confirmed by direct measurements of PAF that, similarly to the cat, is released in response to HCl in the esophageal lumen. It is of interest to note that the acid-filled mucosa does not increase production of IL-6 (Fig. 11) and that, although production of IL-1 is increased in the mucosa, IL-1 is not released in the supernatant surrounding the mucosal sac (Fig. 11). These data point to PAF as a major inflammatory mediator released by epithelial cells to affect circular muscle contraction.41 PAF inhibits neurally mediated contraction by inhibiting release of acetylcholine from cholinergic neurons (Fig. 12).

Figure 10
Direct application of HCl (pH 4.0, 3 hours) to circular muscle strips (Muscle + HCl) did not change contraction in response to electrical field stimulation (supramaximal voltage, 0.2 ms), when compared to untreated muscle (Muscle). Supernatant of HCl-filled ...
Figure 11
(A) When mucosa was exposed to HCl (pH 4.0, 3 hours), IL-6 did not significantly increase in the mucosa or in the supernatant surrounding the mucosal sac when compared to normal Krebs-treated mucosa (control) samples. (B) When mucosa was exposed to HCl, ...
Figure 12
(A) Incubation of normal esophageal smooth muscle strips in the platelet activating factor (PAF) analog PAF-16 (10-5 M, 1-2 hours) almost abolished contraction in response to electrical field stimulation (EFS) (p < 0.05, ANOVA). (B) EFS-induced ...

The HCl-filled mucosal sac releases PAF into the supernatant41 and addition of a PAF receptor antagonist essentially abolished the supernatant-induced inhibition of neurally-mediated circular muscle contraction (Fig. 10). This indicates that PAF is a major mucosa-derived mediator depressing muscle contraction.41 PAF can also activate the esophageal circular muscle to secrete IL-6.41 The muscle-derived IL-6 then leads to enhanced production of H2O2, which in turn induces the secretion of IL-1.41,42 H2O2 and IL-1 can themselves induce PAF production (Fig. 13). This indicates the existence of a self-perpetuating cycle of inflammation and motility abnormalities that is started by HCl-induced PAF release from the esophageal mucosa.

Figure 13
In the circular muscle platelet activating factor (PAF), released by the mucosa causes production of IL-6, that, in turn activates the enzyme nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, inducing production of H2O2 and IL-1β that, ...

PAF, IL-1 and IL-6 can independently alter neurogenic esophageal muscle contraction, mostly by inhibiting release of acetylcholine.8,57

8. Role of epithelium in HCl-induced inflammation

This mucosal sac model contains a variety of different cell types, including epithelial, mesenchymal, neural, etc, that may contribute to the inflammatory process. As epithelial cells, however, have first contact with acid they may play a critical role in the early pathophysiological events leading to GERD. The esophageal epithelium is embryologically, morphologically and functionally related to the skin epithelium, which is recognized as a major immunological organ.58 Esophageal keratinocytes most likely serve as the initiating cell type in esophageal inflammation by expressing activation and cell adhesion molecules and by secreting a variety of proinflammatory cytokines that affect leukocyte recruitment and activity.59

9. Chemoattractants and activators of peripheral blood leukocytes

In addition to affecting circular muscle contraction, PAF induces production of H2O2 in leukocytes (preferentially in eosinophils)60 and is among the most important inducers of eosinophil function. It is a potent chemoattractant for eosinophils and selectively induces the migration of eosinophils over neutrophils.38,61 PAF has an important role in eosinophil transmigration through basement membrane components,62 it promotes actin polymerization63 and eosinophil adherence to vascular endothelial cells64 and evokes the release of reactive oxygen species.39,40

Several studies have reported that in experimental animal models and in human reflux esophagitis, pro-inflammatory cytokine production may underlie the development of erosive esophagitis,8-12 which is defined by the infiltration of neutrophils and eosinophils into the submucosa. However, the mechanisms whereby acid exposure and PAF lead to the recruitment of immune cells in the esophageal mucosa are not known.

Several factors have been suggested as being chemotactic for neutrophils and eosinophils. IL-8, a CXC chemokine with potent chemotactic activity for neutrophils, is elevated in the esophageal mucosa of esophagitis patients,11,65 suggesting a possible role of IL-8 in the pathogenesis of erosive esophagitis induced by acid reflux. SP is known to be a chemoattractant and activator of lymphocytes, monocytes, mast cells and importantly neutrophils and eosinophils.66

We propose that acid in the lumen of the esophagus activates TRPV1 receptors causing the production and release of PAF, SP and CGRP that, in turn, may attract and activate immune cells contributing to inflammation and injury of the esophageal mucosa.

The rabbit has been used extensively67-71 as a model for the study of the human esophageal mucosa. Rabbit esophageal mucosa, similarly to cat,72 contains TRPV1 receptors and responds to HCl by producing SP, CGRP and PAF. In addition the rabbit esophageal mucosa produces IL-8, that is known to be elevated in GERD and to attract leukocytes, particularly neutrophils.73-77

To understand the inflammatory process in the esophagus it is important to establish which inflammatory mediators are released by HCl-stimulated esophageal mucosa at concentrations sufficient to attract and activate peripheral blood leukocytes. Rabbit esophageal mucosa has been used for these experiments. Peripheral blood leukocytes (PBL) were used to examine cell migration in response to the inflammatory mediators/chemokines present in the supernatant of the HCl-stimulated mucosal sac. PBL migration in response to IL-8 and to mucosal supernatant has been examined by using a migration chamber. Figure 14 shows that IL-8 induces PBL migration. PBL migration induced by supernatant of HCl-treated mucosa was comparable to that induced by IL-8. Selective antagonists were used to assess the individual contribution of inflammatory mediators present in the supernatant. The figure shows that a selective CGRP antagonist did not affect PBL migration. In contrast, a selective IL-8 antibody, a PAF receptor antagonist, and an neurokinin-1 receptor antagonist (ie, SP antagonist) significantly reduced PBL migration, supporting a role of IL-8, PAF and SP as relevant chemokines.

Figure 14
Peripheral blood leukocyte (PBL) migration was examined using a dual chamber motility system, where the upper chamber was separated from the lower chamber by a Polycarbonate track-etch membrane with 3 µm pores. Cell migration was allowed to proceed ...

Activated polymorphonuclear leukocytes (including neutrophils, basophils and eosinophils) have been used as the prototype of cells which vigorously produce superoxide anions78 which, in turn, generate other reactive oxygen species (ROS) together with microbiocidal peptides and proteases. ROS comprise species such as superoxide, H2O2, nitric oxide and hydroxyl radicals.79 These highly reactive molecules are known to regulate many important cellular events, including gene expression,80 transcription factor activation,81 DNA synthesis82 and cellular proliferation.83 The enzymes nicotinamide adenine dinucleotide phosphate oxidase (NOX) and dual oxidase generate ROS in a regulated manner, producing reactive oxygen in cells and tissues in response to growth factors, cytokines and calcium signals.84

While activated PBL produce inflammatory products other than H2O2, H2O2 may be used as a model for PBL-derived ROS because H2O2 is physiologically produced in large amounts by cells such as granulocytes, is relatively stable and has been widely used to assess the effects of ROS.79

H2O2 levels, taken as measure of PBL activation, increased when PBL are exposed to sac supernatant at pH 5 (Fig. 15). The contribution of the individual mediators to PBL activation may be assessed by using the appropriate antagonists. The increase was not affected by a CGRP antagonist or by IL-8 neutralization, suggesting that neither CGRP nor IL-8, at the concentrations present in the supernatant, play a role in inducing H2O2 production by PBL. In contrast, a PAF antagonist and a neurokinin-1 receptor antagonist (ie, SP antagonist) significantly reduce supernatant-induced H2O2 production.

Figure 15
To examine the effect of mucosal supernatant on H2O2 production, peripheral blood leukocyte (PBL) were incubated for 20 minutes at 37[degree celsius] in mucosal supernatant from sac incubated in Krebs buffer alone (control) or in acidified Krebs buffer (pH 5.0, ...

Thus the inflammatory mediators produced by HCl exposure may act as chemokines, as immune cells activators, or both. In our system, IL-8 acts only as a chemokine, substance P and PAF act as both chemokines and activators, CGRP, does neither. The data suggest that PBL migration and H2O2 production may be different functions, possibly depending on different signal transduction pathways.

These results, derived from an ex vivo model mimicking reflux-induced events in vivo, identifies the type and quantity of inflammatory mediators likely produced in GERD. Since cellular immune infiltrate is a prerequisite for severe inflammation and tissue damage, inhibition of IL-8, SP and PAF-induced PBL migration and activation may provide potential targets for therapy.

Chronic Esophagitis: Role of Platelet Activating Factor and Hydrogen Peroxide

The previous data were obtained in normal human and animal esophageal specimens after short (3 hours) exposure of esophageal mucosa to acid, and short (3 hours) exposure of circular muscle to mucosa supernatant. To examine whether the data may also be applicable to chronic esophagitis, we refer to a human organ donor specimen with histologically demonstrated erosive esophagitis (Fig. 16).85 In this specimen, the circular muscle was taken from the lower esophageal sphincter (LES). Essentially the same inflammatory processes are present in the body of the esophagus and in the LES. This is not surprising as the inflammation begins with damage to the epithelial cells in the mucosa, that are not different from epithelial cells in the body of the esophagus.

Figure 16
An esophageal specimen obtained from an organ donor exhibited hyperemia of the mucosa with scattered hemorrhagic erosions in the lower esophagus, extending across the cardia. (A) Gross finging shows erosions, basal zone hyperplasia and elongation of lamina ...

When mounted in a warm (37[degree celsius]) oygenated muscle chamber, normal-LES circular muscle strips gradually develop tone and reach a steady state tone after 3-4 hours. In contrast, circular muscle strips from esophagitis LES develop little tone, falling outside of the normal tone minus 2 standard deviations. When circular muscle strips from the esophagitis LES were exposed to the H2O2 scavenger catalase, tone increased and reached a value similar to that of strips from normal LES (Fig. 17). These findings suggest that H2O2 may be present in circular muscle of esophagitis LES, and responsible for reduced tone when inflammation is present.

Figure 17
Circular muscle strips were mounted in muscle chambers, stretched to 2.5 g to bring them near conditions of optimum force development, and equilibrated for 4-6 hours while perfused continuously with oxygenated physiologic salt solution at 37[degree celsius]. ...

Upregulation of NOXs is a possible mechanism for overproduction of H2O2. The NOXs present in human esophageal circular muscle, and possibly upregulated by esophagitis were examined by RT-PCR. Whereas NOX1-NOX5 are all present in esophageal circular muscle, only NOX5 mRNA was increased in the human specimen with esophagitis, as shown in Figure 18A. Increased NOX5 mRNA in the esophagitis specimen was confirmed by real-time RT-PCR, when compared to normal human esophageal circular muscle, as shown in Figure 18B.

Figure 18
Lower esophageal sphincter (LES) circular muscle was examined by reverse transcriptase-polymerase chain reaction (RT-PCR) for the presence of nicotinamide adenine dinucleotide phosphate (NADPH) oxidases. We used published primers for NOX1-NOX5, and found ...

Figure 19 shows H2O2 levels in normal and esophagitis circular muscle tissue. Basal H2O2 levels were elevated in circular muscle of esophagitis LES, exceeding normal levels by more than 2 standard deviations.

Figure 19
Esophagitis increases H2O2 treatment of muscle strips from the esophagitis specimen with the levels in lower esophageal sphincter (LES) circular smooth muscle, as measured by a colorimetric assay. H2O2 levels were 4-fold higher in LES muscle from the ...

PAF levels were elevated in the circular muscle of the human esophagitis sample and exceeded those of the normal sample by more than 2 standard deviations (Fig. 20). Incubation of normal LES circular muscle in H2O2 (70 M, 2 hours) significantly increased PAF levels (p < 0.01).

Figure 20
Esophagitis and H2O2 increase platelet activating factor (PAF) production in lower esophageal sphincter (LES). The PAF concentration was quantified by using a 3[H] PAF scintillation proximity assay system (Amersham Pharmacia Biotech Inc, Princeton, NJ, ...

Conclusion

Epithelial cells, not only constitute the first barrier to diffusion of refluxate, but are important participants in inflammation as they respond to HCl-mediated activation of TRPV1 by releasing cytokines and inflammatory mediators. Cytokines and inflammatory mediators may diffuse to the circular muscle layer affecting contraction and may attract and activate immune cells. PAF and IL-8 produced by epithelial cells, together with SP released from submucosal neurons attract peripheral blood leukocytes, that are activated by both PAF and SP to produce H2O2. H2O2 is uncharged, freely diffusible through cellular membranes, and likely to interact with membrane lipids, causing lipid peroxidation and peroxidation-induced inflammatory mediators. H2O2 may contribute to further production of PAF and cause upregulation of NOX in the mucosa and muscle. H2O2 may also interact with DNA bases (more than 20 different oxidatively altered purines and pyrimidines have been detected and characterized),86 perhaps inducing alterations of cell phenotype and possibly resulting in permanent mutations. The data are summarized in Figure 21.

Figure 21
The data suggest that exposure of esophageal mucosa to acid activates transient receptor potential channel vanilloid subfamily member-1 receptors, inducing neurally-mediated formation of substance P (SP) and calcitonin gene related peptide and production ...

Footnotes

Financial support: This study was supported by NIH grant RO1 DK57030.

Conflicts of interest: None.

References

1. Fass R. Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol. 2007;41:131–137. [PubMed]
2. Locke GR, 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ., 3rd Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448–1456. [PubMed]
3. Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet. 2006;367:2086–2100. [PubMed]
4. Orlando RC. Reflux esophagitis: overview. Scand J Gastroenterol Suppl. 1995;210:36–37. [PubMed]
5. Orlando RC. Pathophysiology of gastroesophageal reflux disease. J Clin Gastroenterol. 2008;42:584–588. [PubMed]
6. Livstone EM, Sheahan DG, Behar J. Studies of esophageal epithelial cell proliferation in patients with reflux esophagitis. Gastroenterology. 1977;73:1315–1319. [PubMed]
7. Souza RF, Huo X, Mittal V, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology. 2009;137:1776–1784. [PubMed]
8. Cao W, Cheng L, Behar J, Fiocchi C, Biancani P, Harnett KM. Proinflammatory cytokines alter/reduce esophageal circular muscle contraction in experimental cat esophagitis. Am J Physiol Gastrointest Liver Physiol. 2004;287:G1131–G1139. [PubMed]
9. Cheng L, Cao W, Fiocchi C, Behar J, Biancani P, Harnett KM. In vitro model of acute esophagitis in the cat. Am J Physiol Gastrointest Liver Physiol. 2005;289:G860–G869. [PubMed]
10. Fitzgerald RC, Onwuegbusi BA, Bajaj-Elliott M, Saeed IT, Burnham WR, Farthing MJ. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut. 2002;50:451–459. [PMC free article] [PubMed]
11. Isomoto H, Wang A, Mizuta Y, et al. Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. Am J Gastroenterol. 2003;98:551–556. [PubMed]
12. Yoshida N, Uchiyama K, Kuroda M, et al. Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease. Scand J Gastroenterol. 2004;39:816–822. [PubMed]
13. Paterson WG, Kieffer CA, Feldman MJ, Miller DV, Morris GP. Role of platelet-activating factor in acid-induced esophageal mucosal injury. Dig Dis Sci. 2007;52:1861–1866. [PubMed]
14. Rieder F, Biancani P, Harnett K, Yerian L, Falk GW. Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. Am J Physiol Gastrointest Liver Physiol. 2010;298:G571–G581. [PubMed]
15. Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev. 1999;51:159–212. [PubMed]
16. Cortright DN, Szallasi A. Biochemical pharmacology of the vanilloid receptor TRPV1. An update. Eur J Biochem. 2004;271:1814–1819. [PubMed]
17. Yiangou Y, Facer P, Dyer NH, et al. Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet. 2001;357:1338–1339. [PubMed]
18. Chan CL, Facer P, Davis JB, et al. Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet. 2003;361:385–391. [PubMed]
19. Matthews PJ, Aziz Q, Facer P, Davis JB, Thompson DG, Anand P. Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus. Eur J Gastroenterol Hepatol. 2004;16:897–902. [PubMed]
20. Guarino MP, Cheng L, Ma J, et al. Increased TRPV1 gene expression in esophageal mucosa of patients with non-erosive and erosive reflux disease. Neurogastroenterol Motil. 2010;22:746–751. e219. [PubMed]
21. Veronesi B, Carter JD, Devlin RB, Simon SA, Oortgiesen M. Neuropeptides and capsaicin stimulate the release of inflammatory cytokines in a human bronchial epithelial cell line. Neuropeptides. 1999;33:447–456. [PubMed]
22. Mantyh CR, Maggio JE, Mantyh PW, Vigna SR, Pappas TN. Increased substance P receptor expression by blood vessels and lymphoid aggregates in Clostridium difficile-induced pseudomembranous colitis. Dig Dis Sci. 1996;41:614–620. [PubMed]
23. Mantyh CR, McVey DC, Vigna SR. Extrinsic surgical denervation inhibits Clostridium difficile toxin A-induced enteritis in rats. Neurosci Lett. 2000;292:95–98. [PubMed]
24. Mantyh CR, Pappas TN, Lapp JA, et al. Substance P activation of enteric neurons in response to intraluminal Clostridium difficile toxin A in the rat ileum. Gastroenterology. 1996;111:1272–1280. [PubMed]
25. Mantyh CR, Vigna SR, Bollinger RR, Mantyh PW, Maggio JE, Pappas TN. Differential expression of substance P receptors in patients with Crohn's disease and ulcerative colitis. Gastroenterology. 1995;109:850–860. [PubMed]
26. Mantyh PW, DeMaster E, Malhotra A, et al. Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science. 1995;268:1629–1632. [PubMed]
27. McVey DC, Schmid PC, Schmid HH, Vigna SR. Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1) J Pharmacol Exp Ther. 2003;304:713–722. [PubMed]
28. McVey DC, Vigna SR. The capsaicin VR1 receptor mediates substance P release in toxin A-induced enteritis in rats. Peptides. 2001;22:1439–1446. [PubMed]
29. McVey DC, Vigna SR. The role of leukotriene B4 in Clostridium difficile toxin A-induced ileitis in rats. Gastroenterology. 2005;128:1306–1316. [PubMed]
30. Nathan JD, Patel AA, McVey DC, et al. Capsaicin vanilloid receptor-1 mediates substance P release in experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2001;281:G1322–G1328. [PubMed]
31. Nathan JD, Peng RY, Wang Y, McVey DC, Vigna SR, Liddle RA. Primary sensory neurons: a common final pathway for inflammation in experimental pancreatitis in rats. Am J Physiol Gastrointest Liver Physiol. 2002;283:G938–G946. [PubMed]
32. Barbara G, De Giorgio R, Stanghellini V, et al. Neutral endopeptidase (EC 3.4.24.11) downregulates the onset of intestinal inflammation in the nematode infected mouse. Gut. 2003;52:1457–1464. [PMC free article] [PubMed]
33. Kirkwood KS, Bunnett NW, Maa J, et al. Deletion of neutral endopeptidase exacerbates intestinal inflammation induced by Clostridium difficile toxin A. Am J Physiol Gastrointest Liver Physiol. 2001;281:G544–G551. [PubMed]
34. Sturiale S, Barbara G, Qiu B, et al. Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proc Natl Acad Sci USA. 1999;96:11653–11658. [PubMed]
35. Kimball ES, Wallace NH, Schneider CR, D'Andrea MR, Hornby PJ. Vanilloid receptor 1 antagonists attenuate disease severity in dextran sulphate sodium-induced colitis in mice. Neurogastroenterol Motil. 2004;16:811–818. [PubMed]
36. Kihara N, de la Fuente SG, Fujino K, Takahashi T, Pappas TN, Mantyh CR. Vanilloid receptor-1 containing primary sensory neurones mediate dextran sulphate sodium induced colitis in rats. Gut. 2003;52:713–719. [PMC free article] [PubMed]
37. Fujino K, de la Fuente SG, Takami Y, Takahashi T, Mantyh CR. Attenuation of acid induced oesophagitis in VR-1 deficient mice. Gut. 2006;55:34–40. [PMC free article] [PubMed]
38. Wardlaw AJ, Moqbel R, Cromwell O, Kay AB. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest. 1986;78:1701–1706. [PMC free article] [PubMed]
39. Shute JK, Rimmer SJ, Akerman CL, Church MK, Holgate ST. Studies of cellular mechanisms for the generation of superoxide by guinea-pig eosinophils and its dissociation from granule peroxidase release. Biochem Pharmacol. 1990;40:2013–2021. [PubMed]
40. Zoratti EM, Sedgwick JB, Vrtis RR, Busse WW. The effect of platelet-activating factor on the generation of superoxide anion in human eosinophils and neutrophils. J Allergy Clin Immunol. 1991;88:749–758. [PubMed]
41. Cheng L, Cao W, Behar J, Fiocchi C, Biancani P, Harnett KM. Acid-induced release of platelet-activating factor by human esophageal mucosa induces inflammatory mediators in circular smooth muscle. J Pharmacol Exp Ther. 2006;319:117–126. [PubMed]
42. Cheng L, Cao W, Fiocchi C, Behar J, Biancani P, Harnett KM. HCl-induced inflammatory mediators in cat esophageal mucosa and inflammatory mediators in esophageal circular muscle in an in vitro model of esophagitis. Am J Physiol Gastrointest Liver Physiol. 2006;290:G1307–G1317. [PubMed]
43. Southall MD, Li T, Gharibova LS, Pei Y, Nicol GD, Travers JB. Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J Pharmacol Exp Ther. 2003;304:217–222. [PubMed]
44. Ständer S, Moormann C, Schumacher M, et al. Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures. Exp Dermatol. 2004;13:129–139. [PubMed]
45. Birder LA, Kanai AJ, de Groat WC, et al. Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci USA. 2001;98:13396–13401. [PubMed]
46. Birder LA, Nakamura Y, Kiss S, et al. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci. 2002;5:856–860. [PubMed]
47. Reilly CA, Taylor JL, Lanza DL, Carr BA, Crouch DJ, Yost GS. Capsaicinoids cause inflammation and epithelial cell death through activation of vanilloid receptors. Toxicol Sci. 2003;73:170–181. [PMC free article] [PubMed]
48. Heiner I, Eisfeld J, Halaszovich CR, et al. Expression profile of the transient receptor potential (TRP) family in neutrophil granulocytes: evidence for currents through long TRP channel 2 induced by ADP-ribose and NAD. Biochem J. 2003;371:1045–1053. [PubMed]
49. Chen CW, Lee ST, Wu WT, Fu WM, Ho FM, Lin WW. Signal transduction for inhibition of inducible nitric oxide synthase and cyclooxygenase-2 induction by capsaicin and related analogs in macrophages. Br J Pharmacol. 2003;140:1077–1087. [PMC free article] [PubMed]
50. Vaccaro DE. Applications of magnetic separation: cell sorting. Am Biotechnol Lab. 1990;8:30, 32–35. [PubMed]
51. Nagano S, Huang X, Moir RD, Payton SM, Tanzi RE, Bush AI. Peroxidase activity of cyclooxygenase-2 (COX-2) cross-links beta-amyloid (Abeta) and generates Abeta-COX-2 hetero-oligomers that are increased in Alzheimer's disease. J Biol Chem. 2004;279:14673–14678. [PubMed]
52. Deaton J, Savva CG, Sun J, Holzenburg A, Berry J, Young R. Solubilization and delivery by GroEL of megadalton complexes of the lambda holin. Protein Sci. 2004;13:1778–1786. [PubMed]
53. Dutta S, Haynes JD, Moch JK, Barbosa A, Lanar DE. Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites. Proc Natl Acad Sci USA. 2003;100:12295–122300. [PubMed]
54. Chaudhuri TK, Farr GW, Fenton WA, Rospert S, Horwich AL. GroEL/GroES-mediated folding of a protein too large to be encapsulated. Cell. 2001;107:235–246. [PubMed]
55. Ilver D, Arnqvist A, Ogren J, et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science. 1998;279:373–377. [PubMed]
56. Ma J, Harnett KM, Behar J, Biancani P, Cao W. Signaling in TRPV1-induced platelet activating factor (PAF) in human esophageal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2010;298:G233–G240. [PubMed]
57. Cheng L, Cao W, Fiocchi C, Behar J, Biancani P, Harnett KM. Platelet-activating factor and prostaglandin E2 impair esophageal ACh release in experimental esophagitis. Am J Physiol Gastrointest Liver Physiol. 2005;289:G418–G428. [PubMed]
58. Williams IR, Kupper TS. Immunity at the surface: homeostatic mechanisms of the skin immune system. Life Sci. 1996;58:1485–1507. [PubMed]
59. Irnich H, Geissel H, Nolden F, et al. Half-life measurements of bare, mass-resolved isomers in a storage-cooler ring. Phys Rev Lett. 1995;75:4182–4185. [PubMed]
60. Kato M, Kita H, Tachibana A, Hayashi Y, Tsuchida Y, Kimura H. Dual signaling and effector pathways mediate human eosinophil activation by platelet-activating factor. Int Arch Allergy Immunol. 2004;134(suppl 1):37–43. [PubMed]
61. Sigal CE, Valone FH, Holtzman MJ, Goetzl EJ. Preferential human eosinophil chemotactic activity of the platelet-activating factor (PAF) 1-0-hexadecyl-2-acetyl-sn-glyceryl-3-phosphocholine (AGEPC) J Clin Immunol. 1987;7:179–184. [PubMed]
62. Okada S, Kita H, George TJ, Gleich GJ, Leiferman KM. Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines. Am J Respir Cell Mol Biol. 1997;16:455–463. [PubMed]
63. Suzuki M, Kato M, Hanaka H, Izumi T, Morikawa A. Actin assembly is a crucial factor for superoxide anion generation from adherent human eosinophils. J Allergy Clin Immunol. 2003;112:126–133. [PubMed]
64. Kimani G, Tonnesen MG, Henson PM. Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor. J Immunol. 1988;140:3161–3166. [PubMed]
65. Isomoto H, Saenko VA, Kanazawa Y, et al. Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease. Am J Gastroenterol. 2004;99:589–597. [PubMed]
66. O'Connor TM, O'Connell J, O'Brien DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol. 2004;201:167–180. [PubMed]
67. Tobey NA, Orlando RC. Mechanisms of acid injury to rabbit esophageal epithelium. Role of basolateral cell membrane acidification. Gastroenterology. 1991;101:1220–1228. [PubMed]
68. Carney CN, Orlando RC, Powell DW, Dotson MM. Morphologic alterations in early acid-induced epithelial injury of the rabbit esophagus. Lab Invest. 1981;45:198–208. [PubMed]
69. Orlando RC, Powell DW, Carney CN. Pathophysiology of acute acid injury in rabbit esophageal epithelium. J Clin Invest. 1981;68:286–293. [PMC free article] [PubMed]
70. Lanas A, Royo Y, Ortego J, Molina M, Sáinz R. Experimental esophagitis induced by acid and pepsin in rabbits mimicking human reflux esophagitis. Gastroenterology. 1999;116:97–107. [PubMed]
71. Naya MJ, Pereboom D, Ortego J, Alda JO, Lanas A. Superoxide anions produced by inflammatory cells play an important part in the pathogenesis of acid and pepsin induced oesophagitis in rabbits. Gut. 1997;40:175–181. [PMC free article] [PubMed]
72. Cheng L, de la Monte S, Ma J, et al. HCl-activated neural and epithelial vanilloid receptors (TRPV1) in cat esophageal mucosa. Am J Physiol Gastrointest Liver Physiol. 2009;297:G135–G143. [PubMed]
73. Mukaida N. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol. 2000;72:391–398. [PubMed]
74. Zeilhofer HU, Schorr W. Role of interleukin-8 in neutrophil signaling. Curr Opin Hematol. 2000;7:178–182. [PubMed]
75. Baggiolini M, Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett. 1992;307:97–101. [PubMed]
76. Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol. 1994;56:559–564. [PubMed]
77. Zwahlen R, Walz A, Rot A. In vitro and in vivo activity and pathophysiology of human interleukin-8 and related peptides. Int Rev Exp Pathol. 1993;34(Pt B):27–42. [PubMed]
77a. Ma J, Altomare A, de la Monte SM, et al. HCl-induced inflammatory mediators in esophageal mucosa increase migration and production of H2O2 by peripheral blood leukocytes. Am J Physiol Gastrointest Liver Physiol. 2010;299:G791–G798. [PubMed]
78. Karnovsky MJ. Robert Feulgen Lecture 1994. Cytochemistry and reactive oxygen species: a retrospective. Histochemistry. 1994;102:15–27. [PubMed]
79. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 1990;186:1–85. [PubMed]
80. Nose K, Shibanuma M, Kikuchi K, Kageyama H, Sakiyama S, Kuroki T. Transcriptional activation of early-response genes by hydrogen peroxide in a mouse osteoblastic cell line. Eur J Biochem. 1991;201:99–106. [PubMed]
81. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 1991;10:2247–2258. [PubMed]
82. Klaunig JE, Xu Y, Isenberg JS, et al. The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect. 1998;106(suppl 1):289–295. [PMC free article] [PubMed]
83. Murrell GA, Francis MJ, Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J. 1990;265:659–665. [PubMed]
84. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol. 2004;4:181–189. [PubMed]
85. Cheng L, Harnett KM, Cao W, et al. Hydrogen peroxide reduces lower esophageal sphincter tone in human esophagitis. Gastroenterology. 2005;129:1675–1685. [PubMed]
86. Dizdaroglu M. Oxidative damage to DNA in mammalian chromatin. Mutat Res. 1992;275:331–342. [PubMed]

Articles from Journal of Neurogastroenterology and Motility are provided here courtesy of The Korean Society of Neurogastroenterology and Motility